- CRS Publications
- News
News
Authors:
Date:
Business Wire: October 3, 2016 – MIAMI, FL and NEW YORK, NY, U.S.A. – Noven Pharmaceuticals, Inc., today announced the appointment of Ralph Lipp, Ph.D., as the company’s new vice president and chief scientific officer. In this role, Dr. Lipp will lead all research and development efforts for Noven’…
Authors:
Date:
Business Wire: September 26, 2016 – CAMBRIDGE, MA, U.S.A. – Dicerna Pharmaceuticals, Inc. (Nasdaq:DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, today announced that the company will focus its resources on its proprietary GalXC™ technology platform to advance…
Authors:
Date:
Business Wire: September 20, 2016 – PALM BEACH GARDENS, FL, U.S.A. – Transdermal Delivery Solutions Corporation (TDSC) announced today the signing of a product license arrangement with ALZYN, LLC, of St. Petersburg, Florida.
“We are pleased to announce the finalization of our agreement for this…
Authors:
Date:
Business Wire: September 20, 2016 – NEW YORK, NY and CAMBRIDGE, MA, U.S.A. – Bristol-Myers Squibb Company (NYSE: BMY) and LabCentral, an innovative, shared laboratory space designed as a launch pad for life-sciences and biotech startups, today announced that PanTher and Suono Bio are the winners of…
Authors:
Date:
Business Wire: September 13, 2016 – WOBURN, MA, U.S.A. – Aphios Corporation today announced that it plans to continue its research to develop a cure for HIV/AIDS using combination drugs in targeted “nanosomes” nanoparticles with recent funding from the National Institute of Allergy and Infectious…
Authors:
Date:
Business Wire: September 13, 2016 – SOMERSET, NJ, U.S.A. – Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, today announced an agreement for Catalent, through its wholly owned…
